[Federal Register Volume 81, Number 182 (Tuesday, September 20, 2016)]
[Notices]
[Page 64508]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22586]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on August 19, 2016, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology 
Enterprise Consortium (``MTEC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, A.G.M. Biological Products Development 
LTD, Nes Ziona, ISRAEL; AbViro, LLC, Bethesda, MD; Actuated Medical, 
Inc., Bellefonte, MD; applied Medical Device Institute (aMDI) GVSU, 
Grand Rapids, MI; Aptus, LLC, Clemson, SC; ARMR Systems, Snellville, 
GA; Axonova Medical, LLC, Philadelphia, PA; Battelle Memorial 
Institute, Columbus, OH; BioBridge Global, San Antonio, TX; Brown 
University, Providence, RI; Combat Wounded Veteran Challenge, Inc., 
Saint Petersburg, FL; DigitalDerm, Inc., Columbia, SC; GeoVax, Inc., 
Smyrna, GA; Health Research, Inc./Wadsworth Center, Menands, NY; IDIQ 
Inc., Fallbrook, CA; INCELL Corporation, LLC, San Antonio, TX; Indiana 
University, Indianapolis, IN; KIYATEC, Inc., Greenville, SC; 
Longeveron, LLC, Miami, FL; Lynntech, Inc., College Station, TX; 
MetArmor, Inc., Glen Garden, NJ; NGT-VC 2021 Limited Partnership 
(NGT3), Nazareth, ISRAEL; Northwestern University, Evanston, IL; 
Organovo, Inc., San Diego, CA; Propagenix, Inc., Rockville, MD; 
Rhythmlink International, LLC, Columbia, SC; Scientific & Biomedical 
Microsystems, LLC (SBM), Glen Burnie, MD; Strategic Marketing 
Innovations, Inc., Washington, DC; Tonix Pharmaceuticals, Inc., New 
York, NY; University of California-Irvine, Irvine, CA; University of 
Cincinnati, Department of Surgery, Cincinnati, OH; University of 
Maryland-Baltimore, Baltimore, MD; and Virtech Bio, LLC, New York, NY, 
have been added as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on March 15, 
2016. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on April 14, 2016 (81 FR 22119).

Patricia A. Brink,
Director of Civil Enforcement, Antitrust Division.
[FR Doc. 2016-22586 Filed 9-19-16; 8:45 am]
 BILLING CODE P